We are live on ! Find out more
GEN

Genesis Healthcare, Inc.
GEN

Delisted

GEN was delisted on the 25th of March, 2021.

77 hedge funds and large institutions have $49.5M invested in Genesis Healthcare, Inc. in 2019 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 22 increasing their positions, 21 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more capital invested

Capital invested by funds: $40.2M → $49.5M (+$9.3M)

22% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 9

3% more funds holding

Funds holding: 7577 (+2)

5% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 21

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
77
Holders Change
+2
Holders Change %
+2.67%
% of All Funds
1.67%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
11
Increased
22
Reduced
21
Closed
9
Calls
$50K
Puts
Net Calls
+$50K
Net Calls Change
-$1.11M
Name Holding Trade Value Shares
Change
Change in
Stake
Jane Street
76
Jane Street
New York
-$41K -35,077 Closed
VF
77
Virtu Financial
New York
-$29K -24,316 Closed
Bank of America
78
Bank of America
North Carolina
-$32.5K -21,951 -98%
JG
79
Jefferies Group
New York
-$23K -19,358 Closed
Susquehanna International Group
80
Susquehanna International Group
Pennsylvania
-$25K -16,860 Closed
Manulife (Manufacturers Life Insurance)
81
Manulife (Manufacturers Life Insurance)
Ontario, Canada
-$17K -14,650 Closed
Bank of Montreal
82
Bank of Montreal
Ontario, Canada
-$1.16K -784 -96%
LTFS
83
Ladenburg Thalmann Financial Services
Florida
-$1K -750 Closed
Royal Bank of Canada
84
Royal Bank of Canada
Ontario, Canada
+$273 +184 New
Group One Trading
85
Group One Trading
Illinois
+$297 +200 New

GEN Hedge Fund Activity: Q1 2019 in Review

77 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Genesis Healthcare, Inc. (GEN) for Q1 2019, worth a combined $49.5M — up 23% from $40.2M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new GEN positions and 9 closed out — a net gain of 2 holders — while 22 added to existing stakes and 21 trimmed.

The largest buyer was V3 Capital Management, adding an estimated $881K. The largest seller was D.E. Shaw & Co, cutting an estimated $805K.

  • 77 institutional investors held Genesis Healthcare, Inc. (GEN) as of Q1 2019, up from 75 in Q4 2018.
  • Funds reported $49.5M of Genesis Healthcare, Inc. stock for Q1 2019, up 23% quarter-over-quarter.
  • 11 funds opened new Genesis Healthcare, Inc. positions in Q1 2019 and 9 closed out, a net change of +2 holders.
  • The largest Genesis Healthcare, Inc. buyer in Q1 2019 was V3 Capital Management, an estimated $881K added.
  • The largest Genesis Healthcare, Inc. seller in Q1 2019 was D.E. Shaw & Co, an estimated $805K sold.

Based on aggregated 13F filings for Q1 2019.